Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Naos
Mediktor gets $3.5M to bring clinically-vetted symptom checker to US
By
Jonah Comstock
|
04:37 pm |
October 10, 2018
The Barcelona-based company recently posted 91.3 percent accuracy in a 1,000-patient study.